Relationship between Severity of Visual Field Loss at Presentation and Rate of Visual Field Progression in Glaucoma
To evaluate the relationship between severity of visual field (VF) loss at presentation and rate of VF progression in glaucoma. Clinic-based, retrospective study. We included 512 eyes of 310 primary glaucoma patients. We analyzed the VFs of all subjects of primary glaucoma who had >5 VFs between...
Saved in:
Published in | Ophthalmology (Rochester, Minn.) Vol. 118; no. 2; pp. 249 - 253 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
New York, NY
Elsevier Inc
01.02.2011
Elsevier |
Subjects | |
Online Access | Get full text |
ISSN | 0161-6420 1549-4713 1549-4713 |
DOI | 10.1016/j.ophtha.2010.05.027 |
Cover
Loading…
Abstract | To evaluate the relationship between severity of visual field (VF) loss at presentation and rate of VF progression in glaucoma.
Clinic-based, retrospective study.
We included 512 eyes of 310 primary glaucoma patients.
We analyzed the VFs of all subjects of primary glaucoma who had >5 VFs between 1989 and 2008. Based on the mean deviation (MD), we classified the VF loss as mild (MD > −6 dB), moderate (MD ≤ −6 to ≥ −12 dB) or severe (MD < −12 dB). Guided Progression Analysis software which gives the rate of progression (ROP) of Visual Field Index per year was used to assess the ROP.
Relationship between severity of VF loss at presentation and ROP.
The median duration of follow-up was 6.8 years. The ROP increased (worsened) by 0.02% per year for every dB worsening of MD (P = 0.02) and for every year of increasing age (P = 0.001). Association between MD and ROP showed a significant positive relationship in mild (β = 0.18; P = 0.001) and a significant negative relationship in severe (β = −0.16; P<0.001) VF loss category. Association between MD and ROP was not significant in the moderate VF loss category (β = −0.05; P = 0.61).
In early stages of glaucoma, the ROP worsened as the severity increased, but, in later stages of the disease, ROP became smaller as the severity increased. There is a need for better methods to detect progression in eyes with severe glaucomatous damage.
Proprietary or commercial disclosure may be found after the references. |
---|---|
AbstractList | To evaluate the relationship between severity of visual field (VF) loss at presentation and rate of VF progression in glaucoma.PURPOSETo evaluate the relationship between severity of visual field (VF) loss at presentation and rate of VF progression in glaucoma.Clinic-based, retrospective study.DESIGNClinic-based, retrospective study.We included 512 eyes of 310 primary glaucoma patients.PARTICIPANTSWe included 512 eyes of 310 primary glaucoma patients.We analyzed the VFs of all subjects of primary glaucoma who had >5 VFs between 1989 and 2008. Based on the mean deviation (MD), we classified the VF loss as mild (MD > -6 dB), moderate (MD ≤ -6 to ≥ -12 dB) or severe (MD < -12 dB). Guided Progression Analysis software which gives the rate of progression (ROP) of Visual Field Index per year was used to assess the ROP.METHODSWe analyzed the VFs of all subjects of primary glaucoma who had >5 VFs between 1989 and 2008. Based on the mean deviation (MD), we classified the VF loss as mild (MD > -6 dB), moderate (MD ≤ -6 to ≥ -12 dB) or severe (MD < -12 dB). Guided Progression Analysis software which gives the rate of progression (ROP) of Visual Field Index per year was used to assess the ROP.Relationship between severity of VF loss at presentation and ROP.MAIN OUTCOME MEASURESRelationship between severity of VF loss at presentation and ROP.The median duration of follow-up was 6.8 years. The ROP increased (worsened) by 0.02% per year for every dB worsening of MD (P = 0.02) and for every year of increasing age (P = 0.001). Association between MD and ROP showed a significant positive relationship in mild (β = 0.18; P = 0.001) and a significant negative relationship in severe (β = -0.16; P<0.001) VF loss category. Association between MD and ROP was not significant in the moderate VF loss category (β = -0.05; P = 0.61).RESULTSThe median duration of follow-up was 6.8 years. The ROP increased (worsened) by 0.02% per year for every dB worsening of MD (P = 0.02) and for every year of increasing age (P = 0.001). Association between MD and ROP showed a significant positive relationship in mild (β = 0.18; P = 0.001) and a significant negative relationship in severe (β = -0.16; P<0.001) VF loss category. Association between MD and ROP was not significant in the moderate VF loss category (β = -0.05; P = 0.61).In early stages of glaucoma, the ROP worsened as the severity increased, but, in later stages of the disease, ROP became smaller as the severity increased. There is a need for better methods to detect progression in eyes with severe glaucomatous damage.CONCLUSIONSIn early stages of glaucoma, the ROP worsened as the severity increased, but, in later stages of the disease, ROP became smaller as the severity increased. There is a need for better methods to detect progression in eyes with severe glaucomatous damage. Purpose To evaluate the relationship between severity of visual field (VF) loss at presentation and rate of VF progression in glaucoma. Design Clinic-based, retrospective study. Participants We included 512 eyes of 310 primary glaucoma patients. Methods We analyzed the VFs of all subjects of primary glaucoma who had >5 VFs between 1989 and 2008. Based on the mean deviation (MD), we classified the VF loss as mild (MD > −6 dB), moderate (MD ≤ −6 to ≥ −12 dB) or severe (MD < −12 dB). Guided Progression Analysis software which gives the rate of progression (ROP) of Visual Field Index per year was used to assess the ROP. Main Outcome Measures Relationship between severity of VF loss at presentation and ROP. Results The median duration of follow-up was 6.8 years. The ROP increased (worsened) by 0.02% per year for every dB worsening of MD ( P = 0.02) and for every year of increasing age ( P = 0.001). Association between MD and ROP showed a significant positive relationship in mild (β = 0.18; P = 0.001) and a significant negative relationship in severe (β = −0.16; P <0.001) VF loss category. Association between MD and ROP was not significant in the moderate VF loss category (β = −0.05; P = 0.61). Conclusions In early stages of glaucoma, the ROP worsened as the severity increased, but, in later stages of the disease, ROP became smaller as the severity increased. There is a need for better methods to detect progression in eyes with severe glaucomatous damage. Financial Disclosure(s) Proprietary or commercial disclosure may be found after the references. To evaluate the relationship between severity of visual field (VF) loss at presentation and rate of VF progression in glaucoma. Clinic-based, retrospective study. We included 512 eyes of 310 primary glaucoma patients. We analyzed the VFs of all subjects of primary glaucoma who had >5 VFs between 1989 and 2008. Based on the mean deviation (MD), we classified the VF loss as mild (MD > -6 dB), moderate (MD ≤ -6 to ≥ -12 dB) or severe (MD < -12 dB). Guided Progression Analysis software which gives the rate of progression (ROP) of Visual Field Index per year was used to assess the ROP. Relationship between severity of VF loss at presentation and ROP. The median duration of follow-up was 6.8 years. The ROP increased (worsened) by 0.02% per year for every dB worsening of MD (P = 0.02) and for every year of increasing age (P = 0.001). Association between MD and ROP showed a significant positive relationship in mild (β = 0.18; P = 0.001) and a significant negative relationship in severe (β = -0.16; P<0.001) VF loss category. Association between MD and ROP was not significant in the moderate VF loss category (β = -0.05; P = 0.61). In early stages of glaucoma, the ROP worsened as the severity increased, but, in later stages of the disease, ROP became smaller as the severity increased. There is a need for better methods to detect progression in eyes with severe glaucomatous damage. To evaluate the relationship between severity of visual field (VF) loss at presentation and rate of VF progression in glaucoma. Clinic-based, retrospective study. We included 512 eyes of 310 primary glaucoma patients. We analyzed the VFs of all subjects of primary glaucoma who had >5 VFs between 1989 and 2008. Based on the mean deviation (MD), we classified the VF loss as mild (MD > −6 dB), moderate (MD ≤ −6 to ≥ −12 dB) or severe (MD < −12 dB). Guided Progression Analysis software which gives the rate of progression (ROP) of Visual Field Index per year was used to assess the ROP. Relationship between severity of VF loss at presentation and ROP. The median duration of follow-up was 6.8 years. The ROP increased (worsened) by 0.02% per year for every dB worsening of MD (P = 0.02) and for every year of increasing age (P = 0.001). Association between MD and ROP showed a significant positive relationship in mild (β = 0.18; P = 0.001) and a significant negative relationship in severe (β = −0.16; P<0.001) VF loss category. Association between MD and ROP was not significant in the moderate VF loss category (β = −0.05; P = 0.61). In early stages of glaucoma, the ROP worsened as the severity increased, but, in later stages of the disease, ROP became smaller as the severity increased. There is a need for better methods to detect progression in eyes with severe glaucomatous damage. Proprietary or commercial disclosure may be found after the references. |
Author | Garudadri, Chandra S. Babu, Jonnadula G. Rao, Harsha L. Senthil, Sirisha Kumar, Addepalli U. |
Author_xml | – sequence: 1 givenname: Harsha L. surname: Rao fullname: Rao, Harsha L. email: harshabl.76@gmail.com – sequence: 2 givenname: Addepalli U. surname: Kumar fullname: Kumar, Addepalli U. – sequence: 3 givenname: Jonnadula G. surname: Babu fullname: Babu, Jonnadula G. – sequence: 4 givenname: Sirisha surname: Senthil fullname: Senthil, Sirisha – sequence: 5 givenname: Chandra S. surname: Garudadri fullname: Garudadri, Chandra S. |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23817831$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/20728941$$D View this record in MEDLINE/PubMed |
BookMark | eNqVkl9rFDEUxYNU7Lb6DUTyIj7NmmSS-SMiSLFVWLC06mvIZO64WbPJNslU9tub6WwRFCk-BS6_c8I9556gI-cdIPSckiUltHq9WfrdOq3VkpE8ImJJWP0ILajgbcFrWh6hRcZoUXFGjtFJjBtCSFWV_Ak6ZqRmTcvpAsUrsCoZ7-La7HAH6SeAw9dwC8GkPfYD_mbiqCw-N2B7vPIxYpXwZYAILt0psXI9vlIJ_qIvg_-ewThBxuELq0btt-opejwoG-HZ4T1FX88_fDn7WKw-X3w6e78qtKhEKlpR00Gzti8rOvSqFapveNlRWg1NW_V9XTMA3mloRKtIxyshoOwGziCvXZOmPEWvZt9d8DcjxCS3JmqwVjnwY5QNb3nJ6pJm8sWBHLst9HIXzFaFvbzPKQMvD4CKWtkhKKdN_M2VDa2bO6M3M6dDTirAILWZU0pBGSspkVN5ciPn8uRUniRC5vKymP8hvvd_QPZulkHO8tZAkFEbcBp6E0An2XvzvwbaGmfynj9gD3Hjx-ByT5LKyCSR19NZTVdFp4MitM0Gb_9t8PD_vwByF96b |
CODEN | OPHTDG |
CitedBy_id | crossref_primary_10_1167_iovs_18_25391 crossref_primary_10_1159_000486575 crossref_primary_10_15406_mojt_2016_02_00027 crossref_primary_10_1097_IJG_0000000000000710 crossref_primary_10_5005_jp_journals_10008_1186 crossref_primary_10_1016_j_ajo_2016_06_005 crossref_primary_10_1111_opo_13312 crossref_primary_10_1007_s00417_012_2214_2 crossref_primary_10_1016_j_ophtha_2011_09_021 crossref_primary_10_1016_j_ophtha_2011_09_022 crossref_primary_10_1007_s00417_020_05036_5 crossref_primary_10_4103_IJO_IJO_3238_23 crossref_primary_10_1097_IJG_0b013e31829484c6 crossref_primary_10_1167_iovs_65_1_30 crossref_primary_10_1016_j_ajo_2023_09_017 crossref_primary_10_1167_iovs_62_9_4 crossref_primary_10_1016_j_ajo_2024_06_017 crossref_primary_10_1038_eye_2013_294 crossref_primary_10_1097_IJG_0000000000000146 crossref_primary_10_1167_iovs_61_14_33 crossref_primary_10_1001_jamaophthalmol_2020_0647 crossref_primary_10_1136_bjophthalmol_2016_309401 crossref_primary_10_1016_j_ogla_2018_05_005 crossref_primary_10_1016_j_ajo_2012_05_025 crossref_primary_10_1016_j_optom_2014_07_009 crossref_primary_10_1136_bjophthalmol_2020_315980 crossref_primary_10_1016_j_ophtha_2017_02_027 crossref_primary_10_1038_s41433_021_01603_0 crossref_primary_10_4103_ijo_IJO_1737_22 crossref_primary_10_1038_eye_2013_285 crossref_primary_10_4103_IJO_IJO_2735_23 crossref_primary_10_1097_IJG_0000000000001985 crossref_primary_10_1371_journal_pone_0078630 crossref_primary_10_37039_1982_8551_20220102 crossref_primary_10_3390_bioengineering12030321 crossref_primary_10_1038_eye_2015_17 crossref_primary_10_3341_jkos_2024_65_7_456 crossref_primary_10_1038_eye_2013_77 crossref_primary_10_1167_iovs_18_25421 crossref_primary_10_3390_bioengineering11030250 crossref_primary_10_1097_IJG_0b013e31822e8e37 crossref_primary_10_1167_iovs_18_25140 crossref_primary_10_1136_bmjophth_2023_001575 crossref_primary_10_1097_IJG_0000000000001179 crossref_primary_10_1097_IJG_0000000000002300 crossref_primary_10_1371_journal_pone_0127233 crossref_primary_10_1016_j_ajo_2019_02_015 crossref_primary_10_1038_s41598_020_76154_7 crossref_primary_10_1155_2018_8941489 crossref_primary_10_1007_s40123_019_00222_z crossref_primary_10_1016_j_preteyeres_2016_10_001 |
Cites_doi | 10.1016/j.survophthal.2008.08.006 10.1001/archopht.1992.01080150079033 10.1097/ICU.0b013e3282f493b3 10.1001/archophthalmol.2009.297 10.1080/01621459.1988.10478639 10.1016/S0161-6420(03)00076-9 10.1001/archopht.121.1.48 10.1016/j.ophtha.2004.02.017 10.1007/s004170050262 10.1016/j.ajo.2007.09.038 10.1167/iovs.03-0692 10.1097/00061198-200404000-00007 10.1364/JOSAA.24.001426 10.1016/S0002-9394(00)00487-6 10.1001/archopht.118.4.481 10.1001/archopht.1982.01030030741002 10.1111/j.0006-341X.2000.00645.x 10.1038/sj.eye.6701605 10.1016/S0161-6420(01)00873-9 10.3341/kjo.2004.18.2.106 |
ContentType | Journal Article |
Copyright | 2011 American Academy of Ophthalmology American Academy of Ophthalmology 2015 INIST-CNRS Copyright © 2011 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: 2011 American Academy of Ophthalmology – notice: American Academy of Ophthalmology – notice: 2015 INIST-CNRS – notice: Copyright © 2011 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved. |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.ophtha.2010.05.027 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1549-4713 |
EndPage | 253 |
ExternalDocumentID | 20728941 23817831 10_1016_j_ophtha_2010_05_027 S0161642010006019 1_s2_0_S0161642010006019 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Hyderabad Eye Research Foundation |
GroupedDBID | --- --K .1- .55 .FO .GJ 0R~ 123 1B1 1CY 1P~ 1~5 29N 4.4 457 4G. 53G 5RE 5VS 7-5 71M AAEDT AAEDW AALRI AAQFI AAQQT AAQXK AAXUO ABCQX ABFRF ABJNI ABLJU ABMAC ABOCM ABWVN ACGFO ACGFS ACIUM ACNCT ACRPL ACVFH ADCNI ADMUD ADNMO AEFWE AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AGCQF AGQPQ AIGII AITUG AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMRAJ BELOY C5W CS3 DU5 EBS EFJIC EFKBS EJD F5P FDB FEDTE FGOYB GBLVA HVGLF HZ~ IHE J1W K-O KOM L7B M27 M41 MO0 N4W N9A NQ- O9- OF- OPF OQ~ P2P R2- ROL RPZ SDG SEL SES SSZ UHS UNMZH UV1 WH7 X7M XH2 XPP Z5R ZGI ZXP ADPAM RIG AAIAV AGZHU AHPSJ ALXNB ZA5 AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c565t-9571fc29d361fda95ad843b116f896dd772ee4bce859a0b4655e3bf42e1617083 |
ISSN | 0161-6420 1549-4713 |
IngestDate | Fri Jul 11 03:37:58 EDT 2025 Mon Jul 21 05:53:18 EDT 2025 Mon Jul 21 09:12:19 EDT 2025 Tue Jul 01 01:01:32 EDT 2025 Thu Apr 24 22:58:07 EDT 2025 Fri Feb 23 02:14:11 EST 2024 Sun Feb 23 10:19:11 EST 2025 Tue Aug 26 19:02:29 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Glaucoma Protozoa Eye disease Prognosis Visual field disease Glaucoma (eye) Visual field Rate Visual field defect Evolution Ciliata Ophthalmology |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 CC BY 4.0 Copyright © 2011 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c565t-9571fc29d361fda95ad843b116f896dd772ee4bce859a0b4655e3bf42e1617083 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 20728941 |
PQID | 849432731 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_849432731 pubmed_primary_20728941 pascalfrancis_primary_23817831 crossref_citationtrail_10_1016_j_ophtha_2010_05_027 crossref_primary_10_1016_j_ophtha_2010_05_027 elsevier_sciencedirect_doi_10_1016_j_ophtha_2010_05_027 elsevier_clinicalkeyesjournals_1_s2_0_S0161642010006019 elsevier_clinicalkey_doi_10_1016_j_ophtha_2010_05_027 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2011-02-01 |
PublicationDateYYYYMMDD | 2011-02-01 |
PublicationDate_xml | – month: 02 year: 2011 text: 2011-02-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | New York, NY |
PublicationPlace_xml | – name: New York, NY – name: United States |
PublicationTitle | Ophthalmology (Rochester, Minn.) |
PublicationTitleAlternate | Ophthalmology |
PublicationYear | 2011 |
Publisher | Elsevier Inc Elsevier |
Publisher_xml | – name: Elsevier Inc – name: Elsevier |
References | Smith, Katz, Quigley (bib7) 1996; 37 Schwartz, Takamoto, Martin (bib9) 2004; 13 Nouri-Mahdavi, Hoffman, Coleman (bib21) 2004; 111 Williams (bib15) 2000; 56 (bib4) 2002; 134 Spry, Sparrow, Diamond, Harris (bib20) 2005; 19 Coleman, Miglior (bib2) 2008; 53 Stewart, Kolker, Sharpe (bib3) 2000; 130 Bengtsson, Patella, Heijl (bib19) 2009; 127 Wilson, Walker, Dueker, Crick (bib22) 1982; 100 Leske, Heijl, Hussein (bib5) 2003; 121 Rivera, Bell, Feldman (bib1) 2008; 19 Bengtsson, Heijl (bib12) 2008; 145 Schlottmann, De Cilla, Greenfield (bib17) 2004; 45 Rasker, van den Enden, Bakker, Hoyng (bib8) 2000; 118 Glynn, Rosner (bib14) 1992; 110 Cleveland, Devlin (bib16) 1988; 83 Lichter, Musch, Gillespie (bib6) 2001; 108 Eid, Spaeth, Bitterman, Steinmann (bib10) 2003; 110 Anderson, Patella (bib13) 1999 Suzuki, Shirato, Adachi, Hamada (bib11) 1999; 237 Hood (bib18) 2007; 24 Lee, Kim, Hong (bib23) 2004; 18 Williams (10.1016/j.ophtha.2010.05.027_bib15) 2000; 56 Bengtsson (10.1016/j.ophtha.2010.05.027_bib19) 2009; 127 Lee (10.1016/j.ophtha.2010.05.027_bib23) 2004; 18 Anderson (10.1016/j.ophtha.2010.05.027_bib13) 1999 Hood (10.1016/j.ophtha.2010.05.027_bib18) 2007; 24 Stewart (10.1016/j.ophtha.2010.05.027_bib3) 2000; 130 Glynn (10.1016/j.ophtha.2010.05.027_bib14) 1992; 110 Wilson (10.1016/j.ophtha.2010.05.027_bib22) 1982; 100 Rasker (10.1016/j.ophtha.2010.05.027_bib8) 2000; 118 Bengtsson (10.1016/j.ophtha.2010.05.027_bib12) 2008; 145 Coleman (10.1016/j.ophtha.2010.05.027_bib2) 2008; 53 Eid (10.1016/j.ophtha.2010.05.027_bib10) 2003; 110 Schlottmann (10.1016/j.ophtha.2010.05.027_bib17) 2004; 45 Nouri-Mahdavi (10.1016/j.ophtha.2010.05.027_bib21) 2004; 111 Smith (10.1016/j.ophtha.2010.05.027_bib7) 1996; 37 Rivera (10.1016/j.ophtha.2010.05.027_bib1) 2008; 19 (10.1016/j.ophtha.2010.05.027_bib4) 2002; 134 Lichter (10.1016/j.ophtha.2010.05.027_bib6) 2001; 108 Leske (10.1016/j.ophtha.2010.05.027_bib5) 2003; 121 Schwartz (10.1016/j.ophtha.2010.05.027_bib9) 2004; 13 Cleveland (10.1016/j.ophtha.2010.05.027_bib16) 1988; 83 Suzuki (10.1016/j.ophtha.2010.05.027_bib11) 1999; 237 Spry (10.1016/j.ophtha.2010.05.027_bib20) 2005; 19 22214951 - Ophthalmology. 2012 Jan;119(1):203-4; author reply 204 |
References_xml | – volume: 121 start-page: 48 year: 2003 end-page: 56 ident: bib5 article-title: Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial publication-title: Arch Ophthalmol – volume: 111 start-page: 1627 year: 2004 end-page: 1635 ident: bib21 article-title: Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study publication-title: Ophthalmology – volume: 118 start-page: 481 year: 2000 end-page: 488 ident: bib8 article-title: Rate of visual field loss in progressive glaucoma publication-title: Arch Ophthalmol – volume: 127 start-page: 1610 year: 2009 end-page: 1615 ident: bib19 article-title: Prediction of glaucomatous visual field loss by extrapolation of linear trends publication-title: Arch Ophthalmol – volume: 13 start-page: 120 year: 2004 end-page: 129 ident: bib9 article-title: Increased rate of visual field loss associated with larger initial visual field threshold values on follow-up of open-angle glaucoma publication-title: J Glaucoma – volume: 110 start-page: 381 year: 1992 end-page: 387 ident: bib14 article-title: Accounting for the correlation between fellow eyes in regression analysis publication-title: Arch Ophthalmol – volume: 37 start-page: 1419 year: 1996 end-page: 1428 ident: bib7 article-title: Analysis of progressive change in automated visual fields in glaucoma publication-title: Invest Ophthalmol Vis Sci – volume: 130 start-page: 274 year: 2000 end-page: 279 ident: bib3 article-title: Factors associated with long-term progression or stability in primary open-angle glaucoma publication-title: Am J Ophthalmol – volume: 24 start-page: 1426 year: 2007 end-page: 1430 ident: bib18 article-title: Relating retinal nerve fiber thickness to behavioral sensitivity in patients with glaucoma: application of a linear model publication-title: J Opt Soc Am A Opt Image Sci Vis – volume: 19 start-page: 102 year: 2008 end-page: 106 ident: bib1 article-title: Risk factors for primary open angle glaucoma progression: what we know and what we need to know publication-title: Curr Opin Ophthalmol – volume: 56 start-page: 645 year: 2000 end-page: 646 ident: bib15 article-title: A note on robust variance estimation for cluster-correlated data publication-title: Biometrics – volume: 134 start-page: 499 year: 2002 end-page: 512 ident: bib4 article-title: The Advanced Glaucoma Intervention Study (AGIS): 12 publication-title: Am J Ophthalmol – volume: 45 start-page: 1823 year: 2004 end-page: 1829 ident: bib17 article-title: Relationship between visual field sensitivity and retinal nerve fiber layer thickness as measured by scanning laser polarimetry publication-title: Invest Ophthalmol Vis Sci – volume: 19 start-page: 643 year: 2005 end-page: 651 ident: bib20 article-title: Risk factors for progressive visual field loss in primary open angle glaucoma publication-title: Eye (Lond) – volume: 100 start-page: 737 year: 1982 end-page: 741 ident: bib22 article-title: Risk factors for rate of progression of glaucomatous visual field loss: a computer-based analysis publication-title: Arch Ophthalmol – volume: 237 start-page: 463 year: 1999 end-page: 467 ident: bib11 article-title: Risk factors for the progression of treated primary open-angle glaucoma: a multivariate life-table analysis publication-title: Graefes Arch Clin Exp Ophthalmol – start-page: 121 year: 1999 end-page: 136 ident: bib13 article-title: Automated Static Perimetry – volume: 108 start-page: 1943 year: 2001 end-page: 1953 ident: bib6 article-title: Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery publication-title: Ophthalmology – volume: 83 start-page: 596 year: 1988 end-page: 610 ident: bib16 article-title: Locally-weighted regression: an approach to regression analysis by local fitting publication-title: J Am Stat Assoc – volume: 145 start-page: 343 year: 2008 end-page: 353 ident: bib12 article-title: A visual field index for calculation of glaucoma rate of progression publication-title: Am J Ophthalmol – volume: 53 start-page: S3 year: 2008 end-page: S10 ident: bib2 article-title: Risk factors for glaucoma onset and progression publication-title: Surv Ophthalmol – volume: 110 start-page: 900 year: 2003 end-page: 907 ident: bib10 article-title: Rate and amount of visual loss in 102 patients with open-angle glaucoma followed up for at least 15 years publication-title: Ophthalmology – volume: 18 start-page: 106 year: 2004 end-page: 115 ident: bib23 article-title: Rate of visual field progression in primary open-angle glaucoma and primary angle-closure glaucoma publication-title: Korean J Ophthalmol – volume: 53 start-page: S3 issue: suppl year: 2008 ident: 10.1016/j.ophtha.2010.05.027_bib2 article-title: Risk factors for glaucoma onset and progression publication-title: Surv Ophthalmol doi: 10.1016/j.survophthal.2008.08.006 – volume: 110 start-page: 381 year: 1992 ident: 10.1016/j.ophtha.2010.05.027_bib14 article-title: Accounting for the correlation between fellow eyes in regression analysis publication-title: Arch Ophthalmol doi: 10.1001/archopht.1992.01080150079033 – volume: 19 start-page: 102 year: 2008 ident: 10.1016/j.ophtha.2010.05.027_bib1 article-title: Risk factors for primary open angle glaucoma progression: what we know and what we need to know publication-title: Curr Opin Ophthalmol doi: 10.1097/ICU.0b013e3282f493b3 – volume: 127 start-page: 1610 year: 2009 ident: 10.1016/j.ophtha.2010.05.027_bib19 article-title: Prediction of glaucomatous visual field loss by extrapolation of linear trends publication-title: Arch Ophthalmol doi: 10.1001/archophthalmol.2009.297 – volume: 83 start-page: 596 year: 1988 ident: 10.1016/j.ophtha.2010.05.027_bib16 article-title: Locally-weighted regression: an approach to regression analysis by local fitting publication-title: J Am Stat Assoc doi: 10.1080/01621459.1988.10478639 – volume: 110 start-page: 900 year: 2003 ident: 10.1016/j.ophtha.2010.05.027_bib10 article-title: Rate and amount of visual loss in 102 patients with open-angle glaucoma followed up for at least 15 years publication-title: Ophthalmology doi: 10.1016/S0161-6420(03)00076-9 – volume: 121 start-page: 48 year: 2003 ident: 10.1016/j.ophtha.2010.05.027_bib5 article-title: Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial publication-title: Arch Ophthalmol doi: 10.1001/archopht.121.1.48 – volume: 111 start-page: 1627 year: 2004 ident: 10.1016/j.ophtha.2010.05.027_bib21 article-title: Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study publication-title: Ophthalmology doi: 10.1016/j.ophtha.2004.02.017 – volume: 237 start-page: 463 year: 1999 ident: 10.1016/j.ophtha.2010.05.027_bib11 article-title: Risk factors for the progression of treated primary open-angle glaucoma: a multivariate life-table analysis publication-title: Graefes Arch Clin Exp Ophthalmol doi: 10.1007/s004170050262 – volume: 145 start-page: 343 year: 2008 ident: 10.1016/j.ophtha.2010.05.027_bib12 article-title: A visual field index for calculation of glaucoma rate of progression publication-title: Am J Ophthalmol doi: 10.1016/j.ajo.2007.09.038 – volume: 45 start-page: 1823 year: 2004 ident: 10.1016/j.ophtha.2010.05.027_bib17 article-title: Relationship between visual field sensitivity and retinal nerve fiber layer thickness as measured by scanning laser polarimetry publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.03-0692 – volume: 13 start-page: 120 year: 2004 ident: 10.1016/j.ophtha.2010.05.027_bib9 article-title: Increased rate of visual field loss associated with larger initial visual field threshold values on follow-up of open-angle glaucoma publication-title: J Glaucoma doi: 10.1097/00061198-200404000-00007 – volume: 24 start-page: 1426 year: 2007 ident: 10.1016/j.ophtha.2010.05.027_bib18 article-title: Relating retinal nerve fiber thickness to behavioral sensitivity in patients with glaucoma: application of a linear model publication-title: J Opt Soc Am A Opt Image Sci Vis doi: 10.1364/JOSAA.24.001426 – start-page: 121 year: 1999 ident: 10.1016/j.ophtha.2010.05.027_bib13 article-title: Automated Static Perimetry – volume: 134 start-page: 499 year: 2002 ident: 10.1016/j.ophtha.2010.05.027_bib4 article-title: The Advanced Glaucoma Intervention Study (AGIS): 12 publication-title: Am J Ophthalmol – volume: 37 start-page: 1419 year: 1996 ident: 10.1016/j.ophtha.2010.05.027_bib7 article-title: Analysis of progressive change in automated visual fields in glaucoma publication-title: Invest Ophthalmol Vis Sci – volume: 130 start-page: 274 year: 2000 ident: 10.1016/j.ophtha.2010.05.027_bib3 article-title: Factors associated with long-term progression or stability in primary open-angle glaucoma publication-title: Am J Ophthalmol doi: 10.1016/S0002-9394(00)00487-6 – volume: 118 start-page: 481 year: 2000 ident: 10.1016/j.ophtha.2010.05.027_bib8 article-title: Rate of visual field loss in progressive glaucoma publication-title: Arch Ophthalmol doi: 10.1001/archopht.118.4.481 – volume: 100 start-page: 737 year: 1982 ident: 10.1016/j.ophtha.2010.05.027_bib22 article-title: Risk factors for rate of progression of glaucomatous visual field loss: a computer-based analysis publication-title: Arch Ophthalmol doi: 10.1001/archopht.1982.01030030741002 – volume: 56 start-page: 645 year: 2000 ident: 10.1016/j.ophtha.2010.05.027_bib15 article-title: A note on robust variance estimation for cluster-correlated data publication-title: Biometrics doi: 10.1111/j.0006-341X.2000.00645.x – volume: 19 start-page: 643 year: 2005 ident: 10.1016/j.ophtha.2010.05.027_bib20 article-title: Risk factors for progressive visual field loss in primary open angle glaucoma publication-title: Eye (Lond) doi: 10.1038/sj.eye.6701605 – volume: 108 start-page: 1943 year: 2001 ident: 10.1016/j.ophtha.2010.05.027_bib6 article-title: Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery publication-title: Ophthalmology doi: 10.1016/S0161-6420(01)00873-9 – volume: 18 start-page: 106 year: 2004 ident: 10.1016/j.ophtha.2010.05.027_bib23 article-title: Rate of visual field progression in primary open-angle glaucoma and primary angle-closure glaucoma publication-title: Korean J Ophthalmol doi: 10.3341/kjo.2004.18.2.106 – reference: 22214951 - Ophthalmology. 2012 Jan;119(1):203-4; author reply 204 |
SSID | ssj0006634 |
Score | 2.2469366 |
Snippet | To evaluate the relationship between severity of visual field (VF) loss at presentation and rate of VF progression in glaucoma.
Clinic-based, retrospective... Purpose To evaluate the relationship between severity of visual field (VF) loss at presentation and rate of VF progression in glaucoma. Design Clinic-based,... To evaluate the relationship between severity of visual field (VF) loss at presentation and rate of VF progression in glaucoma.PURPOSETo evaluate the... |
SourceID | proquest pubmed pascalfrancis crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 249 |
SubjectTerms | Biological and medical sciences Disease Progression Diseases of visual field, optic nerve, optic chiasma and optic tracts Female Follow-Up Studies Glaucoma and intraocular pressure Glaucoma, Open-Angle - diagnosis Glaucoma, Open-Angle - physiopathology Humans Intraocular Pressure - physiology Male Medical sciences Middle Aged Miscellaneous Ophthalmology Retrospective Studies Tonometry, Ocular Vision Disorders - diagnosis Vision Disorders - physiopathology Visual Field Tests Visual Fields - physiology |
Title | Relationship between Severity of Visual Field Loss at Presentation and Rate of Visual Field Progression in Glaucoma |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0161642010006019 https://www.clinicalkey.es/playcontent/1-s2.0-S0161642010006019 https://dx.doi.org/10.1016/j.ophtha.2010.05.027 https://www.ncbi.nlm.nih.gov/pubmed/20728941 https://www.proquest.com/docview/849432731 |
Volume | 118 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9pAEF5RIlWVqqrPlD6iPfSGjPxYP_ZI0hBUQhJBaHNbre21IKIGxebSn95TZ71rY-SgpLlYyJo1Xs_n2ZnxN7MIfXMd4hNOE0P2PTVI4HGDksiTpHHfsUKLR6YsTh5feMMZ-XHj3rRaf2uspU0e9qI_99aVPEWrcA70Kqtk_0Oz1UXhBPwG_cIRNAzHR-m4YrLVGVdTAfPQRIufi0yWhwwkTa17DuuhrF282lYcKSbyhCuuwI70lSRuqaYdMidytuQbmAKvO7OX63k-58vfqo1TkYvQ228pQn6a9mqJhgkvsrJDiKTnvHteWKXx98LmXRwXMOterisSTkX97oNlXPPlctGd9RpSxzzc6G8AqewkwrtnTaEpTHauUt3TxV252_S4YIAMJnoLx3ibya1IJDoX6lkGhE_mjjHfWvMqqNamWbVG1au8rVoUNxYQlcu47a2KJ6ipf27PVA0Mdvt1n56MLCOze6Yxlfcib8VSDW7orrCKtlhmM5M1RJ-hAxtCHLuNDvqjya9R5UeAL6g706tploWfBTuxeX_7HKuXa57B656ofVr2B1KFQ3X9Gr3SkRDuK1i_QS2RvkXPx5rr8Q5ldXRjjW5cohuvEqzwigu8YoluzHNcRzcGdGOJ7oZ0Dd14keIS3e_RbHB6fTI09BYhRgSRSG5Q17eSyKax41lJzKnL44A4oWV5SUC9OIYHKwQJ5d68lJuhbBYonDAhtpBxPYQfH1A7XaXiI8LcNmkgwjChMCIILO4SuAwPqIgSCCKiDnLK58si3T9fbuOyZCVR8pYprTCpFWa6DLTSQUY1aq36xzwg75aqY2VtNKzmDPD5wDj_vnEi0-YqY_vwVx-pvW7lTT_iP492sFVNUIYBfuBYHYRLsDFYteSnSJ6K1SZjAaHEgcgJRA4VCLeDTd8OKLE-PXlGn9GLrb34gtr53UZ8hdAhD4_0O_YPXV8RvA |
linkProvider | Library Specific Holdings |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Relationship+between+Severity+of+Visual+Field+Loss+at+Presentation+and+Rate+of+Visual+Field+Progression+in+Glaucoma&rft.jtitle=Ophthalmology+%28Rochester%2C+Minn.%29&rft.au=Rao%2C+Harsha+L.%2C+MD%2C+DNB%2C+B+Opt&rft.au=Kumar%2C+Addepalli+U.%2C+B+Opt&rft.au=Babu%2C+Jonnadula+G.%2C+B+Opt&rft.au=Senthil%2C+Sirisha%2C+MR%2C+FRCS&rft.date=2011-02-01&rft.issn=0161-6420&rft.volume=118&rft.issue=2&rft.spage=249&rft.epage=253&rft_id=info:doi/10.1016%2Fj.ophtha.2010.05.027&rft.externalDBID=ECK1-s2.0-S0161642010006019&rft.externalDocID=1_s2_0_S0161642010006019 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01616420%2FS0161642010X00094%2Fcov150h.gif |